ClinicalTrials.gg
RecruitingNCT04753424Updated Jun 23, 2022

Semitendinosus Graft as Meniscal Transplant

An observational study in Patient Satisfaction, Graft Failure and Osteo Arthritis Knee, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-06-23.

Sponsored by Karolinska Institutet · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2018; still recruiting 8 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
10
Ages
20 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Patient Satisfaction with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Patient Satisfaction · Sweden.

Planned enrollment
11th of 11
10 · median 114
Started
2018
the only one that year
Observational
11 of 18
3 open now
Registered
8th of 18
by date
Lead sponsor
7 of 18
Karolinska Institutet

Among the 18 studies in Patient Satisfaction with a site in Sweden, this one is the 11th largest by planned enrollment of the 11 observational ones that give a count, is the only one that started in 2018, is one of 11 observational ones, and was the 8th registered.

Patient Satisfaction

882 studies on the registry are indexed under Patient Satisfaction; 205 are open to participants now.

Browse Patient Satisfaction studies →

Open to participants now

5 of the 18 studies in Patient Satisfaction with a site in Sweden are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 102 Patient Satisfaction studies recruiting now, 63 (62%) set no upper age limit and 31 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.

This study: 20 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Patient Satisfaction with a site in Sweden, or all of them as a file.
02

Study summary

Removal of meniscal tissue is described to result in poor knee function and a significant risk for future development of osteoarthritis. Different implants have been suggested to substitute a removed meniscus. Meniscal allograft transplantation is not widely available due to costs and availability. The semitendinosus tendon is a known graft with biological properties with potential to remodel and revascularize in an intraarticular environment such as anterior cruciate ligament reconstruction. The objective for this study was to investigate whether the semitendinosus tendon graft could function as a meniscal transplant.

03

Conditions studied

  • Patient Satisfaction
  • Graft Failure
  • Osteo Arthritis Knee
  • ACL
  • Meniscus Tear

Browse trials for

Keywords

  • meniscus transplantation
04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients, both male and female, 20-50 years of age, with previous subtotal or total meniscectomy, suffering from post meniscectomy symptoms are assessed at the outpatient clinic. If inclusion criteria are met, the patients receive information regarding the treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Previous subtotal or total meniscectomy
  • Post meniscectomy symptoms
  • No osteoarthritic changes on radiography more than Ahlbäck 1
  • Knee aligment (hip-knee-angle) +/- 3°
  • No persisting ACL insufficiency

Exclusion criteria

Exclusion Criteria:

  • Difficulty understanding the instructions
  • Current psychiatric diagnosis
  • Smoking
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Interventions

  • ProcedureSurgical technique

    Description of novel surgical technique using autologous semitendinosus graft as meniscus transplant.

06

What researchers measure

Primary outcomes

  1. Failure

    Surgical failure of transplant defined as meniscus symptoms (joint line tenderness, swelling, locking or positive McMurray) resulting in a need for re-arthroscopy and subtotal or total resection of the transplant.

    Time frame: 2 years

Secondary outcomes

  1. Improved subjective knee function

    Patient reported outcome measure using the Knee Injury and Osteoarthritis Outcome Score (KOOS), 0-100 where 100 indicate best possible result.

    Time frame: 2 years

  2. Improved subjective knee function

    Patient reported outcome measure using Lysholm (0-100 where 100 indicate best possible result) and Tegner activity score (0-10, where 10 indicate the highest activity level) .

    Time frame: 2 years

  3. Improved subjective knee function

    Patient reported outcome measure using Euroqol 5 dimensions (EQ-5D) score (quality of life instrument with five dimensions with points from 1 to 3 where 1 indicates no problem and 3 indicate severe problems).

    Time frame: 2 years

  4. Improved subjective knee function

    Patient reported outcome measure using Global score (0-10 where 10 indicate best possible result)

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
  • KISÖS
    Stockholm, 11883, Sweden
    Recruiting
08

References and documents

Publications

  • Kohn D. Autograft meniscus replacement: experimental and clinical results. Knee Surg Sports Traumatol Arthrosc. 1993;1(2):123-5. doi: 10.1007/BF01565466. PubMed 8536007 ↗
  • Johnson LL, Feagin JA Jr. Autogenous tendon graft substitution for absent knee joint meniscus: a pilot study. Arthroscopy. 2000 Mar;16(2):191-6. doi: 10.1016/s0749-8063(00)90035-5. PubMed 10705332 ↗
  • Ayala Mejias JD, Sciamanna RC, Muniesa MP, Perez-Espana LA. A case report of semitendinosus tendon autograft for reconstruction of the meniscal wall supporting a collagen implant. BMC Sports Sci Med Rehabil. 2013 Mar 28;5:4. doi: 10.1186/2052-1847-5-4. PubMed 23557091 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2018 (actual). Primary completion is estimated for Jan 2024, 72 months after the start.

Of 107 non-industry observational studies under Patient Satisfaction, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's planned 72 months is above that.

Counting every sponsor, half of 113 studies reached it within 20 months; a quarter within 7 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2021
First posted
Feb 15, 2021
StartActual
Jan 1, 2018
Primary completionEst.
Jan 1, 2024
CompletionEst.
Jan 1, 2026
Last update
Jun 23, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04753424
Responsible party
Karl O. Eriksson (Associate Professor, Karolinska Institutet) — Principal investigator
First posted
Feb 15, 2021
Start date
Jan 1, 2018
Primary completion
Jan 1, 2024 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Jun 23, 2022

Study contacts

Karl Eriksson, Prof
Contact
karl.eriksson@ki.se
0046707202646
Erik Rönnblad, MD
Contact
erik.ronnblad@ki.se
0046736785549

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion